Oracle finds itself navigating a complex landscape of robust operational expansion and mounting legal challenges. The company confirmed a significant new office lease in Nashville on the same day a prominent law firm announced an investigation into its recent bond offerings, painting a picture of a tech giant aggressively funding its ambitions while attracting regulatory attention.
Nashville Office Expansion Signals Commitment
In a move underscoring its physical growth, Oracle has secured a long-term lease for approximately 10,800 square meters of office space within the Neuhoff complex in Nashville. The property developer, Cousins Properties, confirmed the agreement. This new location will bring Oracle’s total footprint in the city to three sites, housing around 2,000 employees. Teams in cloud engineering, software development, sales, and product management will occupy the space, which offers a view of the company’s future headquarters currently under construction along the Cumberland River.
Bond Offering Investigation Announced
Simultaneously, The Schall Law Firm has initiated a securities investigation on behalf of purchasers of specific Oracle bonds. The core allegation centers on whether Oracle failed to disclose material information at the time of the bond issuance. Specifically, the investigation will examine if the company was already planning to take on substantially more debt to build out its AI infrastructure—a move that could have impacted the creditworthiness of the bonds being offered.
This is not the first legal action of its kind targeting the software behemoth. The same firm previously alerted investors to a separate class action lawsuit filed under the Securities Exchange Act of 1934. That case pertains to purchasers of Oracle securities between June and December 2025, with a lead plaintiff deadline of April 6, 2026.
Debt-Fueled Growth Strategy Under the Microscope
The legal scrutiny is directly tied to Oracle’s aggressive financing strategy. In February, the company announced plans to raise up to $50 billion through debt and equity. It swiftly executed on this plan, raising $30 billion via bonds and convertible preferred stock within days, with the order book reportedly heavily oversubscribed.
Should investors sell immediately? Or is it worth buying Oracle?
This fundraising has contributed to a sharp rise in total debt, which climbed to $108.1 billion from $92.6 billion at the close of the previous fiscal year. Credit rating agency Moody’s currently assigns Oracle a Baa2 rating, which sits two notches above junk status but is lower than the ratings of key competitors like Amazon, Alphabet, Meta, and Microsoft. Should the current investigation mature into a formal class action, it could create a prolonged overhang of legal uncertainty for the stock, irrespective of the company’s business performance.
Strong Fundamentals Contrast with Weak Share Performance
Operationally, Oracle continues to post impressive results. Its third-quarter revenue jumped 22% to $17.2 billion, while GAAP earnings per share increased 24% to $1.27. A key forward-looking metric, remaining performance obligations—which indicates future revenue—surged 325% to $553 billion. Management subsequently raised its revenue forecast for fiscal year 2027 to $90 billion, notably above the then-prevailing analyst consensus of $86.6 billion.
Despite these strong numbers, Oracle’s shares have faced significant pressure. Analysts at J.P. Morgan recently upgraded the stock from Neutral to Overweight, assigning a $210 price target. They argued that the stock’s decline of approximately 55% from its September peak has fundamentally altered its risk-reward profile. Currently, the share price trades about 27% below its level at the start of the year and remains well below its 200-day moving average.
For investors, the announcement of a fresh investigation adds another layer of complexity to the investment thesis, particularly with the April 6, 2026 deadline looming for the related securities act case.
Ad
Oracle Stock: Buy or Sell?! New Oracle Analysis from March 31 delivers the answer:
The latest Oracle figures speak for themselves: Urgent action needed for Oracle investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 31.
Oracle: Buy or sell? Read more here...
